Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
INCY 12.06.2024

About Gravity Analytica
Recent News
- 02.10.2025 - Q4 2024 Incyte Corporation Earnings Conference Call
- 01.21.2025 - Incyte to Report Fourth Quarter and Year-End 2024 Financial Results
- 01.15.2025 - Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo™ (axatilimab-csfr) 9 mg and 22 mg Vial Sizes
Recent Filings
Each RSU vests as to 25% of the shares subject to the RSU on each of the first four anniversaries of the vesting commencement date, subject to the employee's continued service with the Company on each such date.
About
A global biopharmaceutical company on a mission toSolve On.,
For additional information on
View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241206245128/en/
Mediamedia@incyte.com
Investorsir@incyte.com
Source: